Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIBO-Probiotic
NCT07426705Phase 4Not yet recruiting
- Sponsor
- Central Clinical Hospital of the Ministry of the Interior and Administration in Warsaw
- Start
- Feb 2026
- Primary completion
- Jul 2027
01
Overview
A Phase 4 trial of Medilac-S in small intestinal bacterial overgrowth (SIBO), sponsored by Central Clinical Hospital of the Ministry of the Interior and Administration in Warsaw. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
Medilac-S
03
Conditions
small intestinal bacterial overgrowth (SIBO)
Beyond the preview
Go deeper on NCT07426705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07426705.